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Abstract
Introduction
The objective of this study was to examine correlates of 
ever having had a Papanicolaou (Pap) test among women 
who recently delivered a live infant and who resided near 
the US-Mexico border.
Methods
This cross-sectional study included women who deliv-
ered a live infant in Matamoros, Mexico (n = 488) and 
Cameron County, Texas (n = 453). Women were inter-
viewed in the hospital before discharge between August 
21 and November 9, 2005. Multivariable logistic regres-
sion was used to estimate the odds of ever having had a 
Pap test.
Results
Significantly  fewer  Matamoros  women  (62.1%)  than 
Cameron  County  women  (95.7%)  reported  ever  having 
had a Pap test. Only 12% of Matamoros women said they 
received their most recent Pap test during prenatal care, 
compared with nearly 75% of Cameron County women. 
After adjusting for potential confounders, the odds of ever 
having had a Pap test were 7.41 times greater in Cameron 
County  than  in  Matamoros  (95%  confidence  interval, 
4.07-13.48).
Conclusion
The Healthy Border 2010 goals are to cut cervical can-
cer mortality by 20% to 30% in the border region. The 
significant difference in Pap test prevalence among our 
survey  respondents  may  reflect  that  routine  prenatal 
Pap testing is more common in the United States than 
in Mexico. Because women who are receiving prenatal 
care  have  increased  interaction  with  health  care  pro-
viders, Matamoros providers may need to be educated 
about the need to screen for cervical cancer during this 
time.
Introduction
Cervical cancer incidence and mortality rates are higher 
among women in Mexico (29.5 per 100,000 and 14.1 per 
100,000, respectively) than among Hispanic women in the 
United States (12.2 per 100,000 and 3.1 per 100,000) (1-3). 
Cervical cancer remains the leading cause of cancer deaths 
among  women  in  Mexico,  accounting  for  16.5%  of  all   
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cancer deaths among women, compared 
with 2.4% in the United States (4).
In  the  United  States,  the  success-
ful implementation of the Papanicolaou 
(Pap) test to screen for precursor lesions 
has  reduced  both  the  incidence  of  and 
mortality  from  cervical  cancer  in  the 
last 50 years (5,6). Despite the initiation 
of  a  national  cervical  cancer  screening 
program  in  Mexico  in  1974,  screening 
rates vary from 15% in very rural areas 
to  64%  in  urban  areas 
(7-9).  Two  previous 
studies  using  bination-
al  samples  found  that 
US residence was asso-
ciated  with  increased 
odds  of  cervical  cancer 
screening  (10,11).  Both 
studies,  however,  had 
low  participation  rates 
and  were  limited  to 
women  aged  40  years 
or  older.  In  Healthy 
Border 2010, the United 
States-Mexico  Border 
Health  Commission  set 
goals  for  a  20%  reduc-
tion  in  cervical  cancer 
mortality for the Mexico 
border population and a 
30% reduction in cervi-
cal cancer mortality for 
the  US  border  popula-
tion (12). To achieve this 
goal,  Pap  testing  cou-
pled  with  appropriate 
follow-up  of  abnormal 
Pap tests must increase 
on both sides of the border.
In countries with no organized screening programs, pre-
natal care offers an opportunity for women who typically 
have minimal contact with a health care provider to get a 
Pap test at least once in their lifetime. We compared the 
prevalence of lifetime cervical cancer screening and iden-
tified predictive factors among women on each side of the 
US-Mexico border who recently gave birth.
Methods
Data collection
The data used in this analysis were 
collected  as  part  of  the  Brownsville-
Matamoros  Sister  City  Project  for 
Women’s  Health  (BMSCP),  which 
began  in  the  US-Mexico  border  sis-
ter  cities  of  Matamoros,  Tamaulipas, 
Mexico,  and  Brownsville,  Cameron 
County,  Texas,  and  was  subsequently 
expanded to encompass 
all of Cameron County 
(Figure).  The  study 
used  a  stratified  sys-
tematic  cluster  sam-
pling probability design 
to  select  women  who 
delivered  live  infants 
in  Matamoros  and 
Cameron  County. 
Strata consisted of hos-
pitals with 100 deliver-
ies per year or more in 
either  locality.  Within 
each  stratum,  specif-
ic  days  were  selected 
by  using  systematic 
sampling,  and  every 
woman who gave birth 
on selected days (within 
a  cluster  of  days)  was 
included in the sample. 
Of the 999 women sam-
pled  on  selected  days 
from August 21 through 
November 9, 2005, 947 
(95%)  completed  inter-
views.  The  BMSCP 
pilot project was reviewed for human subject concerns by 
the Centers for Disease Control and Prevention (CDC) and 
was determined to be “nonresearch” or public health prac-
tice. A more thorough description of the data collection and 
other aspects of the BMSCP is provided elsewhere (13).
Measures
Our 2 outcome variables of interest were ever having 
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Figure. Maps of the US-Mexico Border Region (Top) and of Brownsville, Texas, and 
Matamoros, Tamaulipas, Mexico (Bottom). (The authors thank Allison Abell Banicki 
of the Office of Border Health, Texas Department of State Health Services, for creat-
ing the map of the Texas-Mexico border states and thank Jean W. Parcher, Sylvia 
N. Wilson, and the United States Geological Survey [USGS] for providing the map of 
population density in Brownsville and Matamoros.)had a Pap test and having had a Pap test within the past 
3 years. To assess whether women had ever had a Pap 
test, respondents were asked, “Have you ever had a Pap 
smear test?” Women who responded yes were then asked, 
“How long has it been since your most recent Pap smear?” 
Response options included less than 1 year, 1 to 2 years, 2 
to 3 years, and 3 to 5 years. Women who did not respond to 
either question were coded as missing and excluded from 
the analyses. The final unweighted sample size was 941 
responses distributed between Matamoros (n = 488) and 
Cameron County (n = 453).
Respondents who reported receiving at least 1 Pap test 
were asked, “Why did you have your most recent Pap smear 
test?” The question was open-ended, and responses were cat-
egorized into 1 or more of 11 preset responses: “consultation 
for family planning services,” “consultation for pregnancy 
test,” “to check health before getting pregnant,” “checkup 
during pregnancy,” “routine checkup,” “because the doctor 
sent me,” “because there was a campaign or promotion,” 
“because it was about time,” “gynecological symptoms or 
STD check,” “disease of the cervix,” and “other.”
Health behavior was measured as a composite of 5 vari-
ables. One variable was a measure for risky behaviors for 
HIV or sexually transmitted diseases (STDs) (respondents 
who  indicated  that  they  had  not  participated  in  any  of 
the following behaviors: intravenous drug use in the past 
year; treated for a “sexually transmitted disease,” “sexually 
transmitted  infection,”  or  “venereal  disease”  in  the  past 
year; and more than 2 sex partners in the past year). Three 
variables were defined for the 3 months before the woman’s 
pregnancy: walking for at least 10 minutes daily in a usual 
week, having had an HIV test during the most recent preg-
nancy, and seatbelt use. The last variable was consumption 
of nutritious foods, defined by at least daily consumption of 
fruits, green salad, or vegetables during the 3 months before 
getting pregnant. Positive healthy behaviors were summed 
and coded to identify respondents with 1 or 2 healthy behav-
iors, 3 healthy behaviors, or 4 or 5 healthy behaviors.
Data analysis
We  weighted  the  data  to  account  for  probability  of 
selection,  population  noncoverage,  hospital  noncover-
age,  and  nonresponse.  The  complex  survey  design  was 
taken into account by using SUDAAN Release 9.01 (RTI 
International, Research Triangle Park, North Carolina). 
We analyzed data by place of residence and for the com-
bined border region. Bivariate and multivariate analyses 
were conducted for both outcomes (ever and recent Pap 
test)  with  nearly  identical  results.  Given  these  similar 
findings, we report only results for ever having had a Pap 
test. Differences in the prevalence of the outcome variables 
between women who delivered in Matamoros and women 
who delivered in Cameron County were assessed using a 
χ2 test for independence. Statistical significance was set 
at P < .05. Differences could not be assessed between the 
individual  sides  of  the  US-Mexico  border  and  the  com-
bined data because the combined data were a composite 
of the data from individual sides of the US-Mexico border 
and observations were not independent.
Logistic regression was used to quantify the difference 
in the odds of the outcome variables by respondent char-
acteristics. Variables that were statistically significant in 
the bivariate analyses were included in the multivariable 
logistic  regression  models.  Variables  that  approached 
significance (P > .05 but < .10) were also included in the 
logistic  regression  model  to  account  for  other  potential 
sources of variance and confounders. Only variables with 
at least 30 cases unweighted per level were considered in 
the logistic regression analysis. Models were estimated for 
Cameron County and Matamoros separately and for the 
combined sample.
Results
The weighted prevalence of ever having had a Pap test 
was 62.1% among women who lived in Matamoros, com-
pared with 95.7% among women who lived in Cameron 
County. The weighted prevalence of having had a Pap test 
in the previous 3 years was similar at 58.0% and 94.8%, 
respectively (Table 1).
Women primarily delivered in their country of residence. 
Nearly all Matamoros residents completed the interview 
in  Spanish,  compared  with  a  nearly  even  distribution 
between  respondents  who  completed  the  interview  in 
Spanish  or  English  in  Cameron  County.  Of  the  total 
sample, 5% of respondents had an ethnicity other than 
Hispanic (Table 1).
Women who lived in Matamoros but delivered in the 
United States were more likely to have had a Pap test 
(88.8%) compared with women who lived in Matamoros 
and delivered in Mexico (60.7%) (Table 2). In the overall 
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border region, 95.6% of women who delivered in the United 
States  reported  having  had  a  Pap  test  compared  with 
60.6% of the women who delivered in Mexico. Increasing 
age was consistently associated with increased likelihood 
of having had a Pap test.
Maternal  birthplace  in  Mexico  was  associated  with  a 
lower likelihood of ever having had a Pap test among resi-
dents of  Cameron County and the overall border region. 
In Cameron County, the prevalence of ever having had a 
Pap test among women born in Mexico was aproximately   
5 percentage points lower than that among women born in 
the United States. This disparity was nearly 30 percent-
age points in the overall border region.
Women with higher levels of education (≥12 years) in 
each county and overall were more likely to have had a 
Pap  test.  In  Matamoros  and  the  overall  border  region, 
increasing gravidity was associated with an increase in 
the prevalence of ever having had a Pap test. Differences 
between primigravid women and women with 5 or more 
pregnancies were among the largest of any reported.
In  Cameron  County  and  the  overall  border  region, 
women who received any prenatal care were more likely 
to have had a Pap test compared with women who had 
no prenatal care. In Cameron County, the prevalence of 
ever having had a Pap test exceeded 95% among women 
receiving prenatal care but was 32.7% among women who 
received no prenatal care. In the overall border region, a 
similar pattern was observed.
In Matamoros and the overall border region, respondents 
with 4 or 5 healthy behaviors had higher rates of ever hav-
ing had a Pap test. In Matamoros, the prevalence of ever 
having had a Pap test was approximately 18 percentage 
points higher for women with 4 to 5 healthy behaviors 
than for women with fewer healthy behaviors. In the over-
all border region, the difference between these groups was 
slightly greater, approximately 22 percentage points.
Adjusted odds of ever having had a Pap test
After adjusting for other sources of variance, the dispar-
ity in Pap test prevalence persisted between the Cameron 
County  and  Matamoros  (Table  3).  In  the  multivariate 
analysis,  women  who  resided  in  Cameron  County  had 
increased odds of ever having had a Pap test (adjusted 
odds ratio [AOR], 7.41; 95% confidence interval [CI], 4.07-
13.48).
In Cameron County, women aged 19 years and younger 
had  lower  odds  (AOR,  0.32;  95%  CI,  0.10-0.96)  of  ever 
having had a Pap test compared with women aged 25 to 
29 years (Table 3). In Matamoros, women aged 30 to 43 
years had 2.64 (95% CI, 1.37-5.10) times higher odds of 
ever having had a Pap test compared with women aged 25 
to 29 years, which was similar to the increase in the odds 
(AOR, 2.73; 95% CI, 1.49-5.01) in the overall border region. 
In the overall border region, women younger than 25 had 
reduced odds of ever having had a Pap test.
Education  level  was  associated  with  the  odds  of  ever 
having had a Pap test in the Matamoros and overall bor-
der region models (Table 3). In Matamoros and overall, the 
odds of having had a Pap test were lower for women with 
8 to 12 years of education but no diploma, and for women 
with less than 8 years of education than for women who 
had 12 years of education or more with a diploma.
In the Matamoros multivariate model, compared with 
respondents who experienced only 1 pregnancy, experienc-
ing 2 to 4 pregnancies increased the odds of ever having 
had a Pap test by 6.33 times, and experiencing 5 or more 
pregnancies was associated with a 9.74 times increase in 
the odds of ever having had a Pap test. A similar pattern 
was found in the combined analysis. Place of delivery and 
prenatal care did not have an adequate sample size for 
inclusion in the multivariate analysis.
In the multivariate model for Matamoros, among respon-
dents with 4 or 5 healthy behaviors, the odds of ever hav-
ing had a Pap test were 89% higher than for respondents 
with 1 or 2 healthy behaviors. In the multivariate model 
for the overall border region, among respondents with 4 or 
5 healthy behaviors, the odds of ever having had a Pap test 
were 78% higher than for respondents with 1 or 2 healthy 
behaviors.
Reason for having had a Pap test
In Matamoros, a routine checkup (26.8%) and provider 
referral (25.5%) were the 2 most commonly cited reasons 
women gave for getting their most recent screening test 
(Table  4);  12.7%  cited  a  checkup  during  pregnancy.  In 
Cameron County, nearly three-quarters (73.8%) of respon-
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their screening opportunity.
Discussion
This  study  identifies  a  large  disparity  in  Pap  testing 
between women who delivered in Matamoros and those 
who delivered in Cameron County and suggests that pre-
natal care is a valuable opportunity to increase Pap test 
coverage. Rates of Pap testing in Matamoros were simi-
lar to rates reported in other Mexican studies (1,14,15). 
Conversely, in Cameron County, the rates reported in this 
study exceeded previously reported overall rates in Texas 
and rates specific to the Texas-Mexico border, most likely 
because the Cameron County women in our survey had 
just delivered and almost three-quarters of them had had 
a Pap test during prenatal visits (16,17).
Pap testing has been a routine part of prenatal care in 
the United States since the early 1980s (18). Interaction 
with a health care provider during pregnancy may present 
an opportunity for increased use of preventive services, 
including cervical cancer screening and referral. By focus-
ing on women who recently delivered a live infant, this 
study explores cervical cancer screening in a subgroup in 
which the lifetime screening prevalence is expected to be 
much higher. Previous studies have found lifetime Pap test 
screening to be a cost-effective method to reduce disease 
burden,  especially  in  resource-limited  settings  (19-21). 
These data suggest that an opportunity to increase life-
time Pap test prevalence is being missed in Matamoros.
Whether prenatal care represents the best opportunity 
to increase Pap testing is a source of controversy. Nygård 
et al recently evaluated the role of prenatal care in improv-
ing Pap test rates in Norway (22). They concluded that 
this  strategy  needs  to  consider  country-specific  factors 
such as the age at which the incidence of precancerous 
lesions  peaks,  the  age  at  which  human  papillomavirus 
(HPV) prevalence peaks, the mean age of pregnancy, the 
accuracy of the prenatal Pap test to diagnose underlying 
preinvasive lesions, and the impact this strategy may have 
on coverage compared with other strategies (22).
Whether cervical cancer screening needs to be cytology-
based is another heavily debated topic in Latin America. 
Cytology-based screening presents challenges in resource-
limited settings, but recent research has suggested that 
DNA testing for HPV, which uses an assay system, can 
improve access to cervical cancer screening in resource-
limited settings and, because the specimen can be self-
  collected, this type of test may reduce the patient anxiety 
and apprehension sometimes associated with Pap testing. 
However, HPV DNA testing is expensive. On the other 
hand,  visual  inspection  with  acetic  acid  (VIA)  is  more 
affordable for a developing country and is considered more 
accurate than Pap tests (23,24). Although VIA may yield 
some false-positives and lead to overtreatment, VIA offers 
an immediate result, so treatment can be initiated right 
away.
Age and gravidity were positively associated with Pap 
testing.  These  findings  are  expected  when  considering 
the cervical cancer screening guidance in each country. In 
Mexico, routine cervical cancer screening begins at age 25 
and should be conducted every 3 years (1). In the United 
States, most guidelines recommend that a Pap test should 
begin within 3 years after initiating sexual activity or by 
age 21, whichever is earlier (25,26). The most cost-effec-
tive strategies to reduce the burden of cervical cancer in 
low-resource settings is to offer 1 or 2 screenings starting 
at age 35 (21). A recent economic analysis in Mexico con-
cluded that HPV vaccination (when affordable vaccine is 
available) at age 12 and a combination of Pap and HPV 
screening for women aged 25 to 64 years may be more 
beneficial than Pap testing alone (27).
Our  findings  demonstrate  a  need  for  binational  col-
laboration to support healthy behaviors. Women in this 
study who practiced several healthy behaviors had higher 
screening rates. This finding suggests that a coordinated 
binational campaign supporting healthy behaviors would 
not  only  reduce  preventable  illness  and  death  but  also 
could influence cervical cancer screening rates.
Hispanic women in Cameron County were more likely 
to  have  had  a  Pap  test  compared  with  non-Hispanic 
women. This finding is in contrast to previous studies that 
consistently reported a lower prevalence of cervical can-
cer screening among Hispanic women, especially among 
Mexican-origin  Hispanic  women  (16,28-30).  There  are 
several possible explanations for this finding. Barriers to 
cervical cancer screening are perceived pain, lack of knowl-
edge of the test, and not knowing where to go (16,28,29). 
In at least 1 study, Hispanic women cited physician sex 
and insensitivity to patient needs as barriers to cervical 
cancer screening (28). With increasing numbers of women 
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in obstetric practice (31-33), this barrier may not be as 
significant in the prenatal population and may contribute 
to the increased prevalence of lifetime Pap testing in this 
study  population.  Another  possible  explanation  is  that 
the ethnic concentration of Hispanic women in Cameron 
County,  88.9%,  provides  increased  social  support  and 
reduced barriers. Further research is needed to confirm 
and examine possible causes for this finding.
Failure to screen for cervical cancer increases the like-
lihood of late-stage diagnosis, the risk of mortality, and 
health care costs. In Mexico, despite the availability of 
cervical  cancer  screening  for  more  than  35  years,  less 
than  13%  of  preventable  cases  have  been  averted  (4). 
Women who participate in prenatal care have increased 
interaction  with  the  health  care  system.  This  increase 
in  interaction  presents  an  opportunity  to  increase  life-
time  cervical  cancer  screening  prevalence  by  ensuring 
that all women receive screening during prenatal care. 
Increased efforts may be needed to discuss with Mexico’s 
policy makers, physicians, and public health community 
whether prenatal care is the best opportunity to increase 
lifetime Pap testing prevalence and help to achieve the 
Healthy Border 2010 goal of a 20% reduction in cancer 
mortality (12).
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Table 1. Characteristics of Women Who Gave Birth in the US-Mexico Border Region, Brownsville-Matamoros Sister City Project 
for Women’s Health, 2005
Characteristics
 Place of Residence
P valueb
Total Sample Matamoros Cameron County
Unweighted 
Frequency 
(n = 488)a
Weighted 
Frequency (%) 
(n = 2,758)a
Unweighted 
Frequency 
(n = 453)a
Weighted 
Frequency (%) 
(n = 2,310)a
Unweighted 
Frequency 
(n = 941)
Weighted 
Frequency (%) 
(n = 5,068)
Ever had a Pap test
Yes 304 ,3 (62.) 434 2,22 (95.) <.00 38 3,925 (.4)
No 84 ,045 (3.9) 9 99 (4.3) 203 ,43 (22.6)
Had a Pap test within past 3 years 
Yes 284 ,600 (58.0) 430 2,9 (94.8) <.00c 4 3,9 (4.8)
No 204 ,58 (42.0) 23 9 (5.2) 22 ,2 (25.2)
Place of delivery
United States 2 39 (5.0) 452 2,305 (99.8) <.00 49 2,444 (48.2)
Mexico 46 2,68 (95.0) NDd 5 (0.2) 462 2,624 (5.8)
Ethnicity
Hispanic 488 2,58 (00.0) 393 2,003 (88.9) <.00 88 4,6 (95.0)
Non-Hispanic NDe NDe 49 250 (.) 49 250 (5.0)
Age, y
≤19 94 532 (9.3) 66 336 (4.5) .0 60 868 (.)
20-24 54 8 (3.6) 40 5 (30.9) 294 ,586 (3.3)
25-29 35 63 (2.)  59 (25.8) 252 ,359 (26.8)
30-43 05 592 (2.5) 30 662 (28.) 235 ,254 (24.)
Marital status
Not Married 46 258 (9.4) 9 60 (26.4) <.00 65 864 (.)
Married 440 2,489 (90.6) 332 ,694 (3.6) 2 4,82 (82.9)
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Abbreviations: Pap, Papanicolaou; ND, not determined.  
a Columns do not all total to number in sample size because of missing data. 
b χ2 test used to determine statistical differences. 
c Values for having had a Pap test in the last 3 years were so similar to values for having ever had a Pap test that only the latter were analyzed. 
d Cell values of <3 were not used to calculate weighted frequencies.  
e In Matamoros, all women are considered to be of Hispanic ethnicity. Therefore, no data are reported for non-Hispanic ethnicity and the χ2 test was not 
calculated. 
f Respondents who smoked 00 cigarettes in the past 2 years or who smoked any cigarettes on an average day 3 months before this pregnancy. 
g Healthy behaviors were defined as ) not participating in any of the following behaviors: intravenous drug use in the past year, treated for a sexually trans-
mitted infection in the past year, and more than 2 sex partners in the past year; 2) walking for at least 0 minutes daily in a usual week in the 3 months 
before pregnancy; 3) having had an HIV test during the most recent pregnancy; 4) seatbelt use; and 5) consumption of nutritious foods during the 3 months 
before getting pregnant.
(Continued on next page)VOLUME 5: NO. 4
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Characteristics
 Place of Residence
P valueb
Total Sample Matamoros Cameron County
Unweighted 
Frequency 
(n = 488)a
Weighted 
Frequency (%) 
(n = 2,758)a
Unweighted 
Frequency 
(n = 453)a
Weighted 
Frequency (%) 
(n = 2,310)a
Unweighted 
Frequency 
(n = 941)
Weighted 
Frequency (%) 
(n = 5,068)
Education level, y
<8 56 883 (32.0) 55 280 (2.2) <.00 2 ,63 (23.0)
8-2 (no  
diploma)
248 ,404 (50.9) 68 858 (3.3) 46 2,262 (44.)
≥12 (diploma) 84 4 (.0) 228 ,63 (50.5) 32 ,633 (32.3)
Place of birth
United States NDd  25 ,280 (56.4) <.00 253 ,29 (25.8)
Mexico 483 2,29 (98.9) 94 990 (43.6) 6 3,9 (4.2)
Language spoken during interview
English 3  (0.6) 234 ,90 (5.5) <.00 23 ,20 (23.8)
Spanish 485 2,4 (99.4) 29 ,20 (48.5) 04 3,86 (6.2)
Smoked cigarettesf
Yes 24 35 (4.9) 36 84 (8.0) .0 60 39 (6.3)
No 464 2,622 (95.) 46 2,22 (92.0) 880 4,44 (93.)
Age at first sexual intercourse, y
<6 00 565 (20.5) 86 438 (9.) .29 86 ,004 (9.9)
6- 28 26 (26.3) 36 693 (30.2) 264 ,49 (28.)
≥18 260 ,46 (53.2) 228 ,64 (50.8) 488 2,630 (52.0)
Health care coverage
Coverage at any 
time
35 2,026 (3.6) 35 ,605 (69.6) .08 62 3,63 (.8)
No coverage 30 26 (26.4) 3 00 (30.4) 26 ,42 (28.2)
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Abbreviations: Pap, Papanicolaou; ND, not determined.  
a Columns do not all total to number in sample size because of missing data. 
b χ2 test used to determine statistical differences. 
c Values for having had a Pap test in the last 3 years were so similar to values for having ever had a Pap test that only the latter were analyzed. 
d Cell values of <3 were not used to calculate weighted frequencies.  
e In Matamoros, all women are considered to be of Hispanic ethnicity. Therefore, no data are reported for non-Hispanic ethnicity and the χ2 test was not 
calculated. 
f Respondents who smoked 00 cigarettes in the past 2 years or who smoked any cigarettes on an average day 3 months before this pregnancy. 
g Healthy behaviors were defined as ) not participating in any of the following behaviors: intravenous drug use in the past year, treated for a sexually trans-
mitted infection in the past year, and more than 2 sex partners in the past year; 2) walking for at least 0 minutes daily in a usual week in the 3 months 
before pregnancy; 3) having had an HIV test during the most recent pregnancy; 4) seatbelt use; and 5) consumption of nutritious foods during the 3 months 
before getting pregnant.
(Continued on next page)
Table 1. (continued) Characteristics of Women Who Gave Birth in the US-Mexico Border Region, Brownsville-Matamoros Sister 
City Project for Women’s Health, 2005Characteristics
 Place of Residence
P valueb
Total Sample Matamoros Cameron County
Unweighted 
Frequency 
(n = 488)a
Weighted 
Frequency (%) 
(n = 2,758)a
Unweighted 
Frequency 
(n = 453)a
Weighted 
Frequency (%) 
(n = 2,310)a
Unweighted 
Frequency 
(n = 941)
Weighted 
Frequency (%) 
(n = 5,068)
Gravidity
 2 9 (35.2) 32 63 (29.) .09 304 ,644 (32.4)
2-4 29 ,58 (5.2) 26 ,40 (60.9) 555 2,985 (58.9)
≥5 3 208 (.5) 45 230 (0.0) 82 439 (8.)
Entry into prenatal care
st trimester 26 ,29 (44.9) 25 ,403 (6.6) <.00 49 2,62 (52.5)
2nd trimester 228 ,292 (4.6) 52 6 (34.) 380 2,06 (4.4)
3rd trimester 9 0 (3.9) 6 8 (3.6) 35 89 (3.8)
No prenatal care  95 (3.5) NDd 6 (0.) 20  (2.2)
Healthy behaviorsg
 or 2 6 430 (5.6) 24 23 (5.3) <.00 00 553 (0.9)
3 56 882 (32.0) 6 3 (3.5) 2 ,93 (23.5)
4 or 5 256 ,446 (52.4) 368 ,86 (8.2) 624 3,322 (65.5)
 
Abbreviations: Pap, Papanicolaou; ND, not determined.  
a Columns do not all total to number in sample size because of missing data. 
b χ2 test used to determine statistical differences. 
c Values for having had a Pap test in the last 3 years were so similar to values for having ever had a Pap test that only the latter were analyzed. 
d Cell values of <3 were not used to calculate weighted frequencies.  
e In Matamoros, all women are considered to be of Hispanic ethnicity. Therefore, no data are reported for non-Hispanic ethnicity and the χ2 test was not 
calculated. 
f Respondents who smoked 00 cigarettes in the past 2 years or who smoked any cigarettes on an average day 3 months before this pregnancy. 
g Healthy behaviors were defined as ) not participating in any of the following behaviors: intravenous drug use in the past year, treated for a sexually trans-
mitted infection in the past year, and more than 2 sex partners in the past year; 2) walking for at least 0 minutes daily in a usual week in the 3 months 
before pregnancy; 3) having had an HIV test during the most recent pregnancy; 4) seatbelt use; and 5) consumption of nutritious foods during the 3 months 
before getting pregnant.
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Table 2. Prevalence of Lifetime Pap Test Screening Among Women Who Gave Birth in the US-Mexico Border Region, 
Brownsville-Matamoros Sister City Project for Women’s Health, 2005
Characteristic
Place of Residence
Total Sample Matamoros Cameron County
Weighted 
Percentage 
(95% CI) P valuea
Weighted 
Percentage 
(95% CI) P valuea
Weighted 
Percentage 
(95% CI) P valuea
Place of delivery
United States 88.8 (8.5-99.0) .00 96.0 (94.6-9.3) .2 95.6 (94.2-96.9) <.00
Mexico 60. (56.0-65.4) 0 60.6 (55.8-65.3)
Ethnicity
Hispanic 62. (5.6-66.) NDb 9.2 (95.6-98.) .03 6.9 (3.9-9.9) .2
Non-Hispanic NDb 85.3 (5.-94.9) 85.3 (5.-94.9)
Age,y
≤19 39.2 (3.3-4.0) <.00 8.6 (82.0-93.2) <.00 5.9 (5.5-64.4) <.00
20-24 4.3 (40.2-54.4) 95.6 (92.3-98.9) 69. (63.-4.4)
25-29 3. (66.3-9.9) 96.6 (93.9-99.3) 83.4 (9.3-8.5)
30-43 90.4 (86.9-93.9) 99.2 (9.8-00.0) 95. (93.-9.0)
Marital status
Not married 6. (53.5-80.) .45 96.6 (93.8-99.5) .43 8.8 (82.5-93.) <.00
Married 6. (56.8-66.5) 95.4 (93.9-96.) 5.3 (2.0-8.6)
Education level, y
<8 66.5 (59.0-4.0) .002 96.3 (9.-00.0) .03 3. (6.8-9.5) <.00
8-2 (no diploma) 56.3 (5.0-6.) 92. (89.5-95.9) 0. (65.9-4.4)
≥12 (diploma) .2 (62.-9.6) 9.8 (96.2-99.4) 90. (8.0-93.2)
Maternal place of birth
United States 50.0 (0-00.0) .3 98.0 (96.-99.3) .00 9.6 (96.-99.0) <.00
Mexico 62. (5.5-66.8) 92. (89.3-96.0) 0.3 (66.5-4.)
Language spoken during interview
English 66.8 (9.-00.0) .85 9.8 (96.4-99.3) .00 9.4 (95.-99.0) <.00
Spanish 62. (5.5-66.) 93.5 (90.0-96.) .2 (6.5-4.9)
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Abbreviations: Pap, Papanicolaou; CI, confidence interval; ND, not determined. 
a χ2 test used to determine significance. 
b In Matamoros, all women are considered to be of Hispanic ethnicity. Therefore, no data are reported for non-Hispanic ethnicity and the χ2 test was not 
calculated. 
c Respondents who smoked 00 cigarettes in the past 2 years or who smoked any cigarettes on an average day 3 months before this pregnancy. 
d Healthy behaviors were defined as ) not participating in any of the following behaviors: intravenous drug use in the past year, treated for a sexually trans-
mitted infection in the past year, and more than 2 sex partners in the past year; 2) walking for at least 0 minutes daily in a usual week in the 3 months 
before pregnancy; 3) having had an HIV test during the most recent pregnancy; 4) seatbelt use; and 5) consumption of nutritious foods during the 3 months 
before getting pregnant.
(Continued on next page)Characteristic
Place of Residence
Total Sample Matamoros Cameron County
Weighted 
Percentage 
(95% CI) P valuea
Weighted 
Percentage 
(95% CI) P valuea
Weighted 
Percentage 
(95% CI) P valuea
Smoked cigarettesc
Yes 0.5 (52.3-88.8) .3 94.3 (8.-00.0) .6 84.2 (5.5-93.0) .3
No 6. (5.-66.3) 95.8 (94.4-9.3) .0 (4.0-9.9)
Age at first sexual intercourse, y
<6 66.0 (56.-5.8) .44 95.4 (9.4-99.4) .65 8.8 (3.-84.5) .53
6- 63.2 (54.8-.6) 94.6 (9.8-9.4) 8.6 (3.9-83.2)
≥18 60. (54.0-66.2) 96.5 (94.2-98.) 6.2 (2.3-80.)
Health care coverage
Coverage at any time 6.0 (55.6-66.3) .8 9. (96.5-99.0) .02 .2 (3.8-80.) .0
No coverage 65.8 (59.8-.8) 9. (86.-96.) 8.2 (4.-82.4)
Gravidity
 3. (25.8-3.6) <.00 93. (89.3-96.9) .3 56.8 (5.6-62.0) <.00
2-4 .3 (2.-8.9) 96.6 (95.-98.2) 86.4 (83.9-89.0)
≥5 89. (8.2-96.9) 9.8 (94.0-00.0) 93.6 (89.2-98.)
Entry into prenatal care (current pregnancy)
st trimester 66.0 (59.-3.0) .2        95.9 (93.8-98.) <.00 82.0 (8.3-85.) .00
2nd trimester 60.4 (54.8-66.0) 96.0 (93.6-98.3) 3. (69.-.8)
3rd trimester 4.5 (3.5-63.5) 00.0 0. (58.-8.5)
No prenatal care 58.6 (32.4-84.8) 32. (0-9.2) 55.0 (3.6-8.4)
Healthy behaviorsd
 or 2 53.6 (4.5-65.8) <.00 9. (80.6-00.0) .63 62.0 (5.3-2.) <.00
3 52.4 (46.2-58.6) 95.0 (90.5-99.6) 63.5 (58.6-68.4)
4 or 5 0.6 (64.-6.2) 96.2 (94.4-9.9) 85.0 (82.2-8.8)
 
Abbreviations: Pap, Papanicolaou; CI, confidence interval; ND, not determined. 
a χ2 test used to determine significance. 
b In Matamoros, all women are considered to be of Hispanic ethnicity. Therefore, no data are reported for non-Hispanic ethnicity and the χ2 test was not 
calculated. 
c Respondents who smoked 00 cigarettes in the past 2 years or who smoked any cigarettes on an average day 3 months before this pregnancy. 
d Healthy behaviors were defined as ) not participating in any of the following behaviors: intravenous drug use in the past year, treated for a sexually trans-
mitted infection in the past year, and more than 2 sex partners in the past year; 2) walking for at least 0 minutes daily in a usual week in the 3 months 
before pregnancy; 3) having had an HIV test during the most recent pregnancy; 4) seatbelt use; and 5) consumption of nutritious foods during the 3 months 
before getting pregnant.
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Table 3. Adjusted Odds Ratios of Lifetime Pap Test Screening Among Women Who Gave Birth in the US-Mexico Border 
Region, Brownsville-Matamoros Sister City Project for Women’s Health, 2005
Characteristic
Matamoros (n = 488) 
AOR (95% CI)
Cameron County (n = 453) 
AOR (95% CI)
Matamoros and Cameron County (n = 941) 
AOR (95% CI)
Place of residencea
United States NDb NDb .4 (4.0-3.48)
Mexico NDb NDb .00
Ethnicity
Hispanic NDc 4.4 (.28-5.9) NDb
Non-Hispanic NDc .00 NDb
Marital status
Not married NDb NDb 2.59 (.40-4.8)
Married NDb NDb .00
Age, y
≤19 0.6 (0.42-.39) 0.32 (0.0-0.96) 0.50 (0.30-0.82)
20-24 0.44 (0.25-0.8) .2 (0.39-.62) 0.49 (0.30-0.8)
25-29 .00 .00 .00
30-43 2.64 (.3-5.0) 4. (0.-3.42) 2.3 (.49-5.0)
Education level, y
<8 0.55 (0.32-0.96) 3.38 (0.4-2.65) 0.65 (0.40-.04)
8-2 (no diploma) 0.44 (0.2-0.0) 0.68 (0.24-.94) 0.50 (0.32-0.8)
≥12 (with diploma) .00 .00 .00
Maternal place of birth
United States NDb .00 .00
Mexico NDb 0.45 (0.0-2.0) 0.42 (0.4-.26)
Language spoken during interview
English NDb .00 .00
Spanish NDb 0.93 (0.2-4.2) 0.8 (0.30-2.2)
Health care coverage
Coverage at any time NDb 3.4 (0.88-3.65) NDb
No coverage NDb .00 NDb
Abbreviations: Pap, Papanicolaou; AOR, adjusted odds ratio; CI, confidence interval; ND, not determined. 
a Place of residence was used to stratify the residence-specific models and therefore could not be included as a correlate in the model. However, place of 
residence was included in the Matamoros and Cameron County model. 
b Each column represents a separate logistic regression model and all variables included in the model. Variables that satisfy the eligibility criteria for inclusion 
in  model may not for another model. Dashes denote that a variable did not meet the criteria for inclusion in that model, but did for  or more of the other 
models. 
c In Matamoros, all women are considered to be of Hispanic ethnicity. Therefore, no data are reported for non-Hispanic ethnicity and the χ2 test was not 
calculated. 
d Healthy behaviors were defined as ) not participating in any of the following behaviors: intravenous drug use in the past year, treated for a sexually trans-
mitted infection in the past year, and more than 2 sex partners in the past year; 2) walking for at least 0 minutes daily in a usual week in the 3 months 
before pregnancy; 3) having had an HIV test during the most recent pregnancy; 4) seatbelt use; and 5) consumption of nutritious foods during the 3 months 
before getting pregnant.
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Characteristic
Matamoros (n = 488) 
AOR (95% CI)
Cameron County (n = 453) 
AOR (95% CI)
Matamoros and Cameron County (n = 941) 
AOR (95% CI)
Gravidity
 .00 NDb .00
2-4 6.33 (3.95-0.20) NDb 5.3 (3.42-.69)
≥5 9.4 (2.68-35.40) NDb 6.82 (2.5-2.69)
Healthy behaviorsd
 or 2 .00 NDb .00
3 0.9 (0.63-.50) NDb .04 (0.-.53)
4 or 5 .89 (.24-2.88) NDb .8 (.8-2.68)
 
Abbreviations: Pap, Papanicolaou; AOR, adjusted odds ratio; CI, confidence interval; ND, not determined. 
a Place of residence was used to stratify the residence-specific models and therefore could not be included as a correlate in the model. However, place of 
residence was included in the Matamoros and Cameron County model. 
b Each column represents a separate logistic regression model and all variables included in the model. Variables that satisfy the eligibility criteria for inclusion 
in  model may not for another model. ND denotes that a variable did not meet the criteria for inclusion in that model, but did for  or more of the other 
models. 
c In Matamoros, all women are considered to be of Hispanic ethnicity. Therefore, no data are reported for non-Hispanic ethnicity and the χ2 test was not 
calculated. 
d Healthy behaviors were defined as ) not participating in any of the following behaviors: intravenous drug use in the past year, treated for a sexually trans-
mitted infection in the past year, and more than 2 sex partners in the past year; 2) walking for at least 0 minutes daily in a usual week in the 3 months 
before pregnancy; 3) having had an HIV test during the most recent pregnancy; 4) seatbelt use; and 5) consumption of nutritious foods during the 3 months 
before getting pregnant.
Table 4. Reason for Most Recent Pap Test Among Women Who Gave Birth in the US-Mexico Border Region, Brownsville-
Matamoros Sister City Project for Women’s Health, 2005
Reason 
Place of Residence
Total Sample 
Weighted Percentage (95% 
CI)
Matamoros 
Weighted Percentage (95% CI)
Cameron County 
Weighted Percentage (95% CI)
Consultation for family planning services 2. (0.4-3.8) .5 (0.3-2.6) .8 (0.8-2.)
Consultation for pregnancy test 0. (0-.) 0 0.3 (0-0.)
To check health before pregnancy 2.5 (0.-4.3) 0.5 (0-.2) .4 (0.5-2.2)
Checkup during pregnancy 2. (8.9-6.5) 3.8 (69.6-.9) 4. (43.-50.5)
Routine checkup 26.8 (2.-3.9) 2.3 (9.-5.5) 8. (5.8-2.5)
Because the doctor sent me 25.5 (20.4-30.5) 4.2 (2.2-6.2) 3.5 (0.9-6.0)
Because there was a campaign or promotion 3.8 (9.8-.8) 0.2 (0-0.) 6.2 (4.3-8.0)
Because it was about time 0.2 (6.-3.) .5 (4.9-0.0) 8. (6.6-0.)
Had STD/GYN symptoms 2.5 (0.-4.3) 0 . (0.3-.9)
Disease of cervix 3.2 (.-5.3) 0 .4 (0.5-2.3)
 
Abbreviations: Pap, Papanicolaou; CI, confidence interval; STD, sexually transmitted disease; GYN, gynecologic. 
Table 3. (continued) Adjusted Odds Ratios of Lifetime Pap Test Screening Among Women Who Gave Birth in the US-Mexico 
Border Region, Brownsville-Matamoros Sister City Project for Women’s Health, 2005